COMMUNIQUÉS West-GlobeNewswire

Cannabix Technologies Makes Advances with Marijuana Breathalyzer Development and Renews Research with Yost Group
29/05/2019
The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, May 29, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies [...]
Assure Holdings Reports First Quarter 2019 Financial Results
29/05/2019
– Q1 2019 Managed Case Volume Increased 97% to 1,184 – DENVER, May 29, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring [...]
Allogene Therapeutics Announces June 2019 Investor Conference Schedule
29/05/2019
SOUTH SAN FRANCISCO, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for [...]
AIT Therapeutics Announces Study Published in Journal of Cystic Fibrosis
29/05/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, May 29, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
PDS Biotechnology Signs Cooperative Research and Development Agreement with National Cancer Institute to Perform a Phase 2 Clinical Study of PDS0101 in Combination with Other Immune-modulating Agents in Advanced HPV-related Cancers
29/05/2019
BERKELEY HEIGHTS, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional [...]
Coverage Initiated for Endonovo Therapeutics via NetworkNewsWire
29/05/2019
NEW YORK, May 29, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company developing a bioelectronic approach to regenerative medicine, today announces it has [...]
Anchiano Therapeutics Announces Appointment of Salar Roshan as Head of Business Development
29/05/2019
CAMBRIDGE, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies [...]
Minerva Neurosciences to Present at Jefferies 2019 Global Healthcare Conference on June 4, 2019
29/05/2019
WALTHAM, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system [...]
American Cannabis Company, Inc. Announces Strategic Partnership With American Leaf & Joint Submission of Retail Dispensary Application in Massachusetts
29/05/2019
DENVER, CO, May 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business cannabis and hemp consulting solutions provider, wishes to [...]
Pascal Biosciences to Present at 2019 BIO International Convention
29/05/2019
Vancouver, BRITISH COLUMBIA and SEATTLE, May 29, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the Company will [...]
Fluidigm Introduces Automated Advanta Solid Tumor NGS Library Prep Assay Using Microfluidics Technology
29/05/2019
The first commercially available targeted NGS assay that enables simultaneous detection of somatic variants across 53 solid tumor genes using a highly efficient microfluidic library prep workflow SOUTH SAN FRANCISCO, [...]
Menlo Therapeutics to Present at Upcoming Investor Conferences
29/05/2019
REDWOOD CITY, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today [...]
Passage Bio to Present at Jefferies 2019 Healthcare Conference
29/05/2019
PHILADELPHIA, May 29, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases, today announced that [...]
BBS to present at Småbolagsdagen in Stockholm
29/05/2019
BBS – Bioactive Bone Substitutes, an innovator in orthobiologics, today announced that the company’s Chief Commercial Officer (CCO) Paul Watkins will present the company at Småbolagsdagen in Stockholm on June 3, 2019. [...]
Daré Bioscience to Present at the 2019 BIO International Convention
29/05/2019
SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive Officer, will present at the [...]
Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for the Treatment of RDEB
29/05/2019
EXTON, Pa., May 29, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Immunomedics to Participate in Upcoming Healthcare Conferences
29/05/2019
MORRIS PLAINS, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Collegium to Present at Upcoming Investor Conferences
29/05/2019
STOUGHTON, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that [...]
AMAG Pharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference
29/05/2019
WALTHAM, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that William Heiden, president and chief executive officer, will present at the Jefferies 2019 Global Healthcare [...]

Pages